Heme oxygenase-1 protects rat liver against warm ischemia/reperfusion injury via TLR2/TLR4-triggered signaling pathways

World Journal of Gastroenterology

Volumn 21, Issue 10, 2015, Pages 2937-2948

  Huang, Han Fei ^a   Zeng, Zhong ^a   Wang, Kun Hua ^a   Zhang, Hai Yan ^a   Wang, Shuai ^a   Zhou, Wen Xiang ^a   Wang, Zhan Bo ^a   Xu, Wang Gang ^a   Duan, Jian ^a  

^a KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

Heme oxygenase 1; Ischemia reperfusion injury; Liver; Myeloid differentiation factor 88; Toll like receptor

Indexed keywords

BETA INTERFERON; HEME OXYGENASE 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; LACTATE DEHYDROGENASE; MYELOID DIFFERENTIATION FACTOR 88; MYELOPEROXIDASE; PROTOPORPHYRIN COBALT; PROTOPORPHYRIN ZINC; SODIUM CHLORIDE; SUPPRESSOR OF CYTOKINE SIGNALING 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; ENZYME INHIBITOR; HEME OXYGENASE; HMOX1 PROTEIN, RAT; MYD88 PROTEIN, RAT; PROTOPORPHYRIN; TICAM-1 PROTEIN, RAT; TLR2 PROTEIN, RAT; TLR4 PROTEIN, RAT; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; ENZYME ACTIVITY; HISTOLOGY; IMMUNOPRECIPITATION; INFLAMMATORY CELL; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER ISCHEMIA; LIVER PROTECTION; LYMPHOCYTE; MACROPHAGE; MALE; NONHUMAN; PLASMA CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL PROTECTION; DISEASE MODEL; DRUG EFFECTS; ENZYMOLOGY; IMMUNOLOGY; LIVER; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT; WARM ISCHEMIA;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; CYTOPROTECTION; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; HEME OXYGENASE (DECYCLIZING); LIVER; MALE; MYELOID DIFFERENTIATION FACTOR 88; PROTOPORPHYRINS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; WARM ISCHEMIA;

EID: 84924973878     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i10.2937     Document Type: Article

References (51)

1. Kirkby KA, Adin CA. Products of heme oxygenase and their potential therapeutic applications. Am J Physiol Renal Physiol 2006; 290: F563-F571 [PMID: 16461755 DOI: 10.1152/ajprenal.00220.2005]
2. Ryter SW, Otterbein LE, Morse D, Choi AM. Heme oxygenase/carbon monoxide signaling pathways: regulation and functional significance. Mol Cell Biochem 2002; 234-235: 249-263 [PMID: 12162441]
3. Szabo ME, Gallyas E, Bak I, Rakotovao A, Boucher F, de Leiris J, Nagy N, Varga E, Tosaki A. Heme oxygenase-1-related carbon monoxide and flavonoids in ischemic/reperfused rat retina. Invest Ophthalmol Vis Sci 2004; 45: 3727-3732 [PMID: 15452083 DOI: 10.1167/iovs.03-1324]
4. Rushworth SA, Chen XL, Mackman N, Ogborne RM, O'Connell MA. Lipopolysaccharide-induced heme oxygenase-1 expression in human monocytic cells is mediated via Nrf2 and protein kinase C. J Immunol 2005; 175: 4408-4415 [PMID: 16177082]
5. Aggeli IK, Gaitanaki C, Beis I. Involvement of JNKs and p38-MAPK/MSK1 pathways in H2O2-induced upregulation of heme oxygenase-1 mRNA in H9c2 cells. Cell Signal 2006; 18: 1801-1812 [PMID: 16531007 DOI: 10.1016/j.cellsig.2006.02.001]
6. Tamion F, Richard V, Renet S, Thuillez C. Intestinal preconditioning prevents inflammatory response by modulating heme oxygenase-1 expression in endotoxic shock model. Am J Physiol Gastrointest Liver Physiol 2007; 293: G1308-G1314 [PMID: 17823216 DOI: 10.1152/ajpgi.00154.2007]
7. Zeng Z, Huang HF, He F, Wu LX, Lin J, Chen MQ. Diazoxide attenuates ischemia/reperfusion injury via upregulation of heme oxygenase-1 after liver transplantation in rats. World J Gastroenterol 2012; 18: 1765-1772 [PMID: 22553400 DOI: 10.3748/wjg.v18.i15.1765]
8. Zeng Z, Huang HF, Chen MQ, Song F, Zhang YJ. Contributions of heme oxygenase-1 in postconditioning-protected ischemia-reperfusion injury in rat liver transplantation. Transplant Proc 2011; 43: 2517-2523 [PMID: 21911116 DOI: 10.1016/j.transproceed.2011.04.021]
9. Zeng Z, Huang HF, Chen MQ, Song F, Zhang YJ. Postconditioning prevents ischemia/reperfusion injury in rat liver transplantation. Hepatogastroenterology 2010; 57: 875-881 [PMID: 21033245]
10. O'Neill LA, Bowie AG. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol 2007; 7: 353-364 [PMID: 17457343 DOI: 10.1038/nri2079]
11. Katsargyris A, Klonaris C, Alexandrou A, Giakoustidis AE, Vasileiou I, Theocharis S. Toll-like receptors in liver ischemia reperfusion injury: a novel target for therapeutic modulation? Expert Opin Ther Targets 2009; 13: 427-442 [PMID: 19335065 DOI: 10.1517/14728220902794939]
12. Horng T, Barton GM, Medzhitov R. TIRAP: an adapter molecule in the Toll signaling pathway. Nat Immunol 2001; 2: 835-841 [PMID: 11526399 DOI: 10.1038/ni0901-835]
13. Frantz S, Ertl G, Bauersachs J. Mechanisms of disease: Toll-like receptors in cardiovascular disease. Nat Clin Pract Cardiovasc Med 2007; 4: 444-454 [PMID: 17653117 DOI: 10.1038/ncpcardio0938]
14. Verstak B, Nagpal K, Bottomley SP, Golenbock DT, Hertzog PJ, Mansell A. MyD88 adapter-like (Mal)/TIRAP interaction with TRAF6 is critical for TLR2- and TLR4-mediated NF-kappaB proinflammatory responses. J Biol Chem 2009; 284: 24192-24203 [PMID: 19592497 DOI: 10.1074/jbc.M109.023044]
15. Lee SM, Kim EJ, Suk K, Lee WH. CD300F blocks both MyD88 and TRIF-mediated TLR signaling through activation of Src homology region 2 domain-containing phosphatase 1. J Immunol 2011; 186: 6296-6303 [PMID: 21536801 DOI: 10.4049/jimmunol.1002184]
16. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124: 783-801 [PMID: 16497588 DOI: 10.1016/j.cell.2006.02.015]
17. Liew FY, Xu D, Brint EK, O'Neill LA. Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol 2005; 5: 446-458 [PMID: 15928677 DOI: 10.1038/nri1630]
18. Mansell A, Smith R, Doyle SL, Gray P, Fenner JE, Crack PJ, Nicholson SE, Hilton DJ, O'Neill LA, Hertzog PJ. Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. Nat Immunol 2006; 7: 148-155 [PMID: 16415872 DOI: 10.1038/ni1299]
19. Strassheim D, Kim JY, Park JS, Mitra S, Abraham E. Involvement of SHIP in TLR2-induced neutrophil activation and acute lung injury. J Immunol 2005; 174: 8064-8071 [PMID: 15944314]
20. Fang H, Pengal RA, Cao X, Ganesan LP, Wewers MD, Marsh CB, Tridandapani S. Lipopolysaccharide-induced macrophage inflammatory response is regulated by SHIP. J Immunol 2004; 173: 360-366 [PMID: 15210794]
21. Seki E, Brenner DA. Toll-like receptors and adaptor molecules in liver disease: update. Hepatology 2008; 48: 322-335 [PMID: 18506843 DOI: 10.1002/hep.22306]
22. Cai C, Shi X, Korff S, Zhang J, Loughran PA, Ruan X, Zhang Y, Liu L, Billiar TR. CD14 contributes to warm hepatic ischemia-reperfusion injury in mice. Shock 2013; 40: 115-121 [PMID: 23656919 DOI: 10.1097/SHK.0b013e318299d1a7]
23. Chang WJ, Toledo-Pereyra LH. Toll-like receptor signaling in liver ischemia and reperfusion. J Invest Surg 2012; 25: 271-277 [PMID: 22853814 DOI: 10.3109/08941939.2012.687802]
24. Sano T, Izuishi K, Hossain MA, Inoue T, Kakinoki K, Hagiike M, Okano K, Masaki T, Suzuki Y. Hepatic preconditioning using lipopolysaccharide: association with specific negative regulators of the Toll-like receptor 4 signaling pathway. Transplantation 2011; 91: 1082-1089 [PMID: 21403587 DOI: 10.1097/TP.0b013e31821457cb]
25. Paterson HM, Murphy TJ, Purcell EJ, Shelley O, Kriynovich SJ, Lien E, Mannick JA, Lederer JA. Injury primes the innate immune system for enhanced Toll-like receptor reactivity. J Immunol 2003; 171: 1473-1483 [PMID: 12874240]
26. Zeng Z, Huang HF, Chen MQ, Song F, Zhang YJ. Heme oxygenase-1 protects donor livers from ischemia/reperfusion injury: the role of Kupffer cells. World J Gastroenterol 2010; 16: 1285-1292 [PMID: 20222175]
27. Cho WH, Kim DG, Murase N, Mischinger HJ, Todo S, Starzl TE. Comparison of superoxide dismutase, allopurinol, coenzyme Q10, and glutathione for the prevention of warm ischemic injury. Transplantation 1990; 50: 353-355 [PMID: 2382304]
28. Shen XD, Ke B, Zhai Y, Gao F, Anselmo D, Lassman CR, Busuttil RW, Kupiec-Weglinski JW. Stat4 and Stat6 signaling in hepatic ischemia/reperfusion injury in mice: HO-1 dependence of Stat4 disruption-mediated cytoprotection. Hepatology 2003; 37: 296-303 [PMID: 12540779 DOI: 10.1053/jhep.2003.50066]
29. Ke B, Shen XD, Gao F, Tsuchihashi S, Farmer DG, Briscoe D, Busuttil RW, Kupiec-Weglinski JW. The CD154-CD40 T-cell co-stimulation pathway in liver ischemia and reperfusion inflammatory responses. Transplantation 2005; 79: 1078-1083 [PMID: 15880047]
30. Ke B, Shen XD, Gao F, Busuttil RW, Löwenstein PR, Castro MG, Kupiec-Weglinski JW. Gene therapy for liver transplantation using adenoviral vectors: CD40-CD154 blockade by gene transfer of CD40Ig protects rat livers from cold ischemia and reperfusion injury. Mol Ther 2004; 9: 38-45 [PMID: 14741776]
31. Kim SJ, Eum HA, Billiar TR, Lee SM. Role of heme oxygenase 1 in TNF/TNF receptor-mediated apoptosis after hepatic ischemia/reperfusion in rats. Shock 2013; 39: 380-388 [PMID: 23423194 DOI: 10.1097/SHK.0b013e31828aab7f]
32. Cao CX, Yang QW, Lv FL, Cui J, Fu HB, Wang JZ. Reduced cerebral ischemia-reperfusion injury in Toll-like receptor 4 deficient mice. Biochem Biophys Res Commun 2007; 353: 509-514 [PMID: 17188246 DOI: 10.1016/j.bbrc.2006.12.057]
33. Caso JR, Pradillo JM, Hurtado O, Leza JC, Moro MA, Lizasoain I. Toll-like receptor 4 is involved in subacute stress-induced neuroinflammation and in the worsening of experimental stroke. Stroke 2008; 39: 1314-1320 [PMID: 18309167 DOI: 10.1161/STROKEAHA.107.498212]
34. Lehnardt S, Lehmann S, Kaul D, Tschimmel K, Hoffmann O, Cho S, Krueger C, Nitsch R, Meisel A, Weber JR. Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia. J Neuroimmunol 2007; 190: 28-33 [PMID: 17854911 DOI: 10.1016/j.jneuroim.2007.07.023]
35. Yang QW, Lu FL, Zhou Y, Wang L, Zhong Q, Lin S, Xiang J, Li JC, Fang CQ, Wang JZ. HMBG1 mediates ischemia-reperfusion injury by TRIF-adaptor independent Toll-like receptor 4 signaling. J Cereb Blood Flow Metab 2011; 31: 593-605 [PMID: 20700129 DOI: 10.1038/jcbfm.2010.129]
36. O'Neill LA . How Toll-like receptors signal: what we know and what we don't know. Curr Opin Immunol 2006; 18: 3-9 [PMID: 16343886 DOI: 10.1016/j.coi.2005.11.012]
37. Piao W, Song C, Chen H, Diaz MA, Wahl LM, Fitzgerald KA, Li L, Medvedev AE. Endotoxin tolerance dysregulates MyD88- and Toll/IL-1R domain-containing adapter inducing IFN-beta-dependent pathways and increases expression of negative regulators of TLR signaling. J Leukoc Biol 2009; 86: 863-875 [PMID: 19656901 DOI: 10.1189/jlb.0309189]
38. Suzuki N, Suzuki S, Yeh WC. IRAK-4 as the central TIR signaling mediator in innate immunity. Trends Immunol 2002; 23: 503-506 [PMID: 12297423]
39. Krumbach R, Bloor S, Ryzhakov G, Randow F. Somatic cell genetics for the study of NF-kappaB signaling in innate immunity. Sci Signal 2008; 1: pt7 [PMID: 18827221 DOI: 10.1126/scisignal.139pt7]
40. Cook DN, Pisetsky DS, Schwartz DA. Toll-like receptors in the pathogenesis of human disease. Nat Immunol 2004; 5: 975-979 [PMID: 15454920 DOI: 10.1038/ni1116]
41. Fan J, Li Y, Levy RM, Fan JJ, Hackam DJ, Vodovotz Y, Yang H, Tracey KJ, Billiar TR, Wilson MA. Hemorrhagic shock induces NAD(P)H oxidase activation in neutrophils: role of HMGB1-TLR4 signaling. J Immunol 2007; 178: 6573-6580 [PMID: 17475888]
42. Ono M, Yu B, Hardison EG, Mastrangelo MA, Tweardy DJ. Increased susceptibility to liver injury after hemorrhagic shock in rats chronically fed ethanol: role of nuclear factor-kappa B, interleukin-6, and granulocyte colony-stimulating factor. Shock 2004; 21: 519-525 [PMID: 15167680]
43. Sato H, Tanaka T, Tanaka N. The effect of p38 mitogen-activated protein kinase activation on inflammatory liver damage following hemorrhagic shock in rats. PLoS One 2012; 7: e30124 [PMID: 22253904 DOI: 10.1371/journal.pone.0030124]
44. Mosher B, Dean R, Harkema J, Remick D, Palma J, Crockett E. Inhibition of Kupffer cells reduced CXC chemokine production and liver injury. J Surg Res 2001; 99: 201-210 [PMID: 11469888 DOI: 10.1006/jsre.2001.6217]
45. Lentsch AB, Yoshidome H, Cheadle WG, Miller FN, Edwards MJ. Chemokine involvement in hepatic ischemia/reperfusion injury in mice: roles for macrophage inflammatory protein-2 and Kupffer cells. Hepatology 1998; 27: 507-512 [PMID: 9462650 DOI: 10.1002/hep.510270226]
46. Brikos C, Wait R, Begum S, O'Neill LA, Saklatvala J. Mass spectrometric analysis of the endogenous type I interleukin-1 (IL-1) receptor signaling complex formed after IL-1 binding identifies IL-1RAcP, MyD88, and IRAK-4 as the stable components. Mol Cell Proteomics 2007; 6: 1551-1559 [PMID: 17507369 DOI: 10.1074/mcp.M600455-MCP200]
47. Kobayashi K, Hernandez LD, Galán JE, Janeway CA, Medzhitov R, Flavell RA. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 2002; 110: 191-202 [PMID: 12150927]
48. Nakagawa R, Naka T, Tsutsui H, Fujimoto M, Kimura A, Abe T, Seki E, Sato S, Takeuchi O, Takeda K, Akira S, Yamanishi K, Kawase I, Nakanishi K, Kishimoto T. SOCS-1 participates in negative regulation of LPS responses. Immunity 2002; 17: 677-687 [PMID: 12433373]
49. Gabhann JN, Higgs R, Brennan K, Thomas W, Damen JE, Ben Larbi N, Krystal G, Jefferies CA. Absence of SHIP-1 results in constitutive phosphorylation of tank-binding kinase 1 and enhanced TLR3-dependent IFN-beta production. J Immunol 2010; 184: 2314-2320 [PMID: 20100929 DOI: 10.4049/jimmunol.0902589]
50. Sly LM, Hamilton MJ, Kuroda E, Ho VW, Antignano FL, Omeis SL, van Netten-Thomas CJ, Wong D, Brugger HK, Williams O, Feldman ME, Houseman BT, Fiedler D, Shokat KM, Krystal G. SHIP prevents lipopolysaccharide from triggering an antiviral response in mice. Blood 2009; 113: 2945-2954 [PMID: 19139077 DOI: 10.1182/blood-2008-06-166082]
51. Sly LM, Rauh MJ, Kalesnikoff J, Song CH, Krystal G. LPS-induced upregulation of SHIP is essential for endotoxin tolerance. Immunity 2004; 21: 227-239 [PMID: 15308103 DOI: 10.1016/j.immuni.2004.07.010]